| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.59B | 13.28B | 12.30B | 10.37B | 7.83B | 7.14B |
| Gross Profit | 3.41B | 3.80B | 3.40B | 3.32B | 2.56B | 2.28B |
| EBITDA | 1.29B | 2.57B | 1.35B | 2.39B | 2.14B | 2.18B |
| Net Income | -809.38M | -60.52M | -682.43M | 585.35M | 672.52M | -385.79M |
Balance Sheet | ||||||
| Total Assets | 18.37B | 28.55B | 26.99B | 25.53B | 9.81B | 10.37B |
| Cash, Cash Equivalents and Short-Term Investments | 5.05B | 14.01B | 14.07B | 13.17B | 2.86B | 3.42B |
| Total Debt | 3.54B | 7.56B | 1.64B | 1.73B | 12.88M | 515.16M |
| Total Liabilities | 8.43B | 21.98B | 16.86B | 14.70B | 4.85B | 4.61B |
| Stockholders Equity | 9.93B | 6.57B | 10.13B | 10.83B | 4.96B | 5.77B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 491.90M | 1.11B | -2.40B | 1.43B | 765.44M |
| Operating Cash Flow | 0.00 | 1.17B | 3.62B | 533.23M | 2.80B | 2.11B |
| Investing Cash Flow | 0.00 | -3.58B | -2.64B | 4.59B | -1.38B | -1.34B |
| Financing Cash Flow | 0.00 | 2.35B | -83.28M | 5.19B | -1.98B | 485.94M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥422.94B | 12.89 | 14.42% | 4.80% | 3.10% | 2.91% | |
75 Outperform | ¥24.27B | 13.71 | ― | 2.50% | 16.18% | 28.23% | |
67 Neutral | ¥79.61B | 20.71 | ― | 2.02% | 7.88% | 6.55% | |
65 Neutral | ¥39.00B | 20.77 | ― | ― | 9.59% | 25.89% | |
60 Neutral | ¥4.60B | 11.42 | ― | 2.04% | 14.62% | 225.91% | |
55 Neutral | $13.29B | 17.42 | 10.03% | 0.93% | 7.13% | -12.93% | |
51 Neutral | ¥10.53B | -155.62 | ― | ― | 7.94% | 92.47% |